Results 251 to 260 of about 10,242 (284)
Some of the next articles are maybe not open access.
Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy
Movement Disorders, 2002AbstractIn some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop.
Dirk, Dressler, Hans, Bigalke
openaire +2 more sources
Botulinum toxin type A for the treatment of migraine
Expert Opinion on Pharmacotherapy, 2006Migraine is a common and debilitating disorder that often requires prophylactic therapy, particularly for those migraine patients who meet the diagnostic criteria for chronic daily headache (chronic migraine). Existing prophylactic treatments for migraine are inadequate for many patients due to their modest efficacy and/or systemic side effects ...
openaire +2 more sources
Journal of the American Academy of Dermatology, 2005
Alastair, Carruthers, Jean, Carruthers
openaire +2 more sources
Alastair, Carruthers, Jean, Carruthers
openaire +2 more sources
Development and evaluation of a tetravalent botulinum vaccine
Human Vaccines and Immunotherapeutics, 2022Zhi-Ying Li +2 more
exaly
The cosmetic uses of Botulinum toxin type A
International Journal of Dermatology, 1999Anthony V. Benedetto, . Do
openaire +2 more sources
Molecular Characterization of a Novel Botulinum Neurotoxin Type H Gene
Journal of Infectious Diseases, 2014Nir Dover, Jason R Barash, Karen K Hill
exaly
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
Toxins, 2017Michael W Peck +2 more
exaly